Phocas Financial Corp. Meridian Bioscience Inc Transaction History

Phocas Financial Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $2.43 Million - $3.82 Million	-134,740 Closed	0 $0
Q1 2021 Jun 22, 2021	SELL	$19.76 - $29.89 $858,058 - $1.3 Million	-43,424 Reduced 24.37%	134,740 $3.54 Million
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $569,709 - $784,481	-36,218 Reduced 16.89%	178,164 $3.33 Million
Q3 2020 Nov 13, 2020	BUY	$13.54 - $26.41 $92,884 - $181,172	6,860 Added 3.31%	214,382 $3.64 Million
Q2 2020 Aug 24, 2020	BUY	$7.84 - $23.29 $1.63 Million - $4.83 Million	207,522 New	207,522 $4.83 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.